Heart Disease Trial, Recruiting NCT06595147 Sponsor: University of Alberta Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06595147
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 60 years or older
  • People who have previously been diagnosed with early-stage breast cancer (stages I, II, or III)
  • People who finished their main cancer treatment at least one year ago, where that treatment included a type of chemotherapy called anthracyclines or a biological therapy called trastuzumab

Who may not be able to join:

  • People with a history of coronary artery disease, heart failure, certain heart rhythm problems (such as atrial fibrillation), stroke, or chronic obstructive pulmonary disease (a long-term lung condition)
  • People who show signs of reduced blood flow to the heart during a fitness test involving breathing and exercise measurements (confirm with trial site)
  • People who have any medical reason they cannot have an MRI scan (for example, having a pacemaker), or who have a physical limitation that prevents them from completing exercise testing
  • People who are already doing regular structured exercise, defined as 30 minutes or more per day of moderate-to-vigorous aerobic or resistance exercise on four or more days per week
  • People who are not willing to be randomly assigned to either the exercise training group or the stretching group

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 616.566.6756

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
20 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Peak arterio-venous oxygen content difference; Peak cardiac output

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov